Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Axsome Thera
(NQ:
AXSM
)
77.35
+1.42 (+1.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Axsome Thera
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
2 Biotech Stocks You Can Buy and Hold for the Next Decade
January 02, 2024
The types of innovative drugs these companies develop are always in high demand.
Via
The Motley Fool
Prediction: These 3 Stocks Will Soar in 2024
January 01, 2024
Investors could enjoy an especially happy new year with these great stocks.
Via
The Motley Fool
3 Unstoppable Stocks to Buy Right Now
December 10, 2023
These stocks could be just the ticket for investors seeking strong growth.
Via
The Motley Fool
3 Biotech Stocks That Could Be Millionaire Makers
November 22, 2023
Many biotech stocks offer exciting long-term growth prospects.
Via
The Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
Investors shouldn't have to deliberate for too long about these great stocks.
Via
The Motley Fool
3 Healthcare Stocks That Have More Than Doubled in Value Since the Fed Started Raising Interest Rates
November 09, 2023
Can these promising growth stocks continue rising in value?
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
Analyst Expectations for Axsome Therapeutics's Future
November 07, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Analyst Ratings for Axsome Therapeutics
September 25, 2023
Via
Benzinga
Axsome's Strategy on Payer Coverage Slowly Pays Off, Depression Drug Sales Show Growth
November 06, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q3 revenues of $57.8 million, up 244% Y/Y, beating the consensus of $54.75 m
Via
Benzinga
Axsome Therapeutics (AXSM) Q3 2023 Earnings Call Transcript
November 06, 2023
AXSM earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Riding the Wave: 3 Stocks That Can 10X by 2025
October 30, 2023
Are you looking to invest in stocks with the potential to 10x? Here are three stocks that can 10x by 2025.
Via
InvestorPlace
Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now
October 27, 2023
Now, you can scoop up these future growth winners for a bargain.
Via
The Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
October 25, 2023
Neither has performed well on the stock market this year.
Via
The Motley Fool
3 No-Brainer Stocks to Buy Right Now for Less than $100
October 23, 2023
You can start with a small investment and win big over time.
Via
The Motley Fool
2 Top Biotech Stocks Defying the Bear Market
September 15, 2023
The best may be yet to come for these companies.
Via
The Motley Fool
2 No-Brainer Biotech Stocks to Buy Right Now
September 12, 2023
You can get in early on these potential winners.
Via
The Motley Fool
Analyst Ratings for Axsome Therapeutics
August 11, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy in October
October 03, 2023
Growth catalysts lie ahead for both of these players.
Via
The Motley Fool
Axsome Therapeutics Stock Clears Key Benchmark, Hits 80-Plus RS Rating
September 27, 2023
A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance.
Via
Investor's Business Daily
The Top Healthcare Stocks to Buy With $100
August 30, 2023
Both stocks have outperformed the broader market in the last 12 months.
Via
The Motley Fool
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
August 24, 2023
Today's market loser could be tomorrow's market winner.
Via
The Motley Fool
Got $200? 3 Growth Stocks to Buy That Could Double Your Money
August 19, 2023
There's no guarantee that any stock will deliver 2 times returns. But the chances for these stocks look pretty good.
Via
The Motley Fool
Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade
August 15, 2023
A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance.
Via
Investor's Business Daily
3 Explosive Stocks to Buy Right Now
August 10, 2023
These stocks are poised to pop in the not-too-distant future.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
DraftKings To Rally Over 38%? Here Are 10 Other Analyst Forecasts For Tuesday
August 08, 2023
Piper Sandler raised the price target for Chegg, Inc. (NYSE: CHGG) from $11 to $13. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Chegg shares rose 19.9% to $12.03 in pre-market...
Via
Benzinga
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
August 07, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q2 sales of $46.7 million, beating the consensus of $40.19 million.
Via
Benzinga
Axsome Therapeutics (AXSM) Q2 2023 Earnings Call Transcript
August 07, 2023
AXSM earnings call for the period ending June 30, 2023.
Via
The Motley Fool
3 Fantastic Growth Stocks to Buy in August
August 05, 2023
These stocks could be poised to soar.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.